New senior role for ASMI
April 23, 2013
The Australian Self Medication
Industry has signalled an increasing
presence in the complementary
medicines sector, with the
appointment of Brenda Davy as its
new “complementary medicines
strategy manager”.
Davy has extensive experience in
the arena, including recent roles
as Global Category Marketing
Manager for Blackmores and also
as Regional Marketing Director for
Procter & Gamble.
ASMI executive director Deon
Schoombie said the appointment
“reflects the unique demands being
placed on the sector as it manages
exceptional growth and calls for
tighter regulatory controls.
“The place of complementary
medicines has never been so
great, but at the same time there
is a level of scrutiny that is proving
a significant challenge to firms
and the industry more generally,”
Schoombie said.
“With this appointment, we are
aiming to fill a need in the market
for a strategic direction that
can help to build a sustainable,
evidence-based sector that has the
trust and respect of all stakeholders
and most importantly, consumers,”
he added.
Schoombie said ASMI had
recognised the need to add to its
existing strengths, to address “what
is certain to be an ongoing series of
challenges facing the sector” as the
popularity and awareness of CMs
continues to grow.
Davy said she was thrilled at
the new role, which comes at
a very important time for the
complementary medicines sector.
“Consumers and a growing
number of practitioners have
demonstrated their commitment to
using complementary medicines,”
she said, adding that ASMI wants
to work to ensure a growing and
profitable CM sector “and one in
which consumers can have the
eHealth registration utmost confidence”.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Apr 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Apr 13
